UH Med Now

1st International Translational Medicine Conference in Hawaiʻi brings together scientists from China, US, Europe, India, Mexico, Korea

Date: January 8th, 2019 in Faculty, JABSOM News, Research    Print or PDF

Dr. Loic LeMarchand working in a cell storage area in the laboratories at UH Kakaʻako.

Pictured: Dr. Loïc LeMarchand working in a cell storage area in the laboratories at UH Kakaʻako. Courtesy UH Cancer Center.

By UH Med Now

The 1st annual international conference on Translational Medicine this weekend on the Kakaʻako campus of the University of Hawaiʻi John A. Burns School of Medicine (JABSOM). The conference will bring together scientists from China, Korea, Europe, India, Mexico, Hawaiʻi and the U.S. Mainland whose expertise lies in studying various molecular, cellular and genetic aspects of translational medicine.

Translational medicine is a term that describes a growing discipline in biomedical research which aims to expedite the discovery of new diagnostic tools and treatments by using a multi-disciplinary, highly collaborative, “bench-to-bedside” approaches.

Dr. Loïc LeMarchand

Dr. LeMarchand is the conference keynote speaker.

The keynote speaker of the conference on Saturday, January 12 at 9 a.m. is Loïc Le Marchand, MD, PhD, Contact Principal Investigator of the Multiethnic Cohort (MEC) Study, John A. Burns School of Medicine Professor of Cell and Molecular Biology, and University of Hawaiʻi Cancer Center Associate Director for Ethnic Diversity.

According to conference general secretary Youping Deng, JABSOM Professor and Director of The Bioinformatics Core, the hope is to provide a format for the exchange of ideas and information about research on cancer therapy, stem cell therapy and regenerative medicine.

Youping Deng headshot

Youping Deng, Director of the JABSOM Bioinformatics Core, is the conference general secretary.

The scientists are also eager to discuss the latest research findings and technical advances and how they might be applied to chronic diseases including cancer, cardiovascular disease, respiratory disease and bone joint diseases. Stem cell therapies, along with the application of artificial intelligence in biomedicine and in promoting health, as well as topics including the research and development of new drugs are also of interest.

Sessions are scheduled on Saturday, January 12 from 9 a.m. until 6 p.m. and Sunday, January 13 from 9 a.m. until 3 p.m. in the Medical Education Building Auditorium.

More information about the conference including a list of other speakers may be found HERE.

Share this: